American Heart Journal
Volume 157, Issue 6 , Pages 1018-1025 , June 2009

Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: Findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

  • James D. Flaherty, MD

      Affiliations

    • Northwestern University, Chicago, IL
    • ,
  • Joseph S. Rossi, MD

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • ,
  • Gregg C. Fonarow, MD

      Affiliations

    • University of California Los Angeles Medical Center, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, UCLA Division of Cardiology, 10833 LeConte Avenue, Los Angeles, CA 90095-1679.
    • ,
  • Eduardo Nunez, MD

      Affiliations

    • GlaxoSmithKline, Philadelphia, PA
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Duke University Medical Center, Durham, and Campbell University School of Pharmacy, Research Triangle Park, NC
    • ,
  • William T. Abraham, MD

      Affiliations

    • The Ohio State University, Columbus, OH
    • ,
  • Nancy M. Albert, PhD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • University of California San Diego, San Diego, CA
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Baylor University Medical Center, Dallas, TX
    • ,
  • James B. Young, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Charles J. Davidson, MD

      Affiliations

    • Northwestern University, Chicago, IL
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Northwestern University, Chicago, IL

Received 18 January 2009 ,Accepted 6 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Clinical Trial.gov identifier: NCT00344513.

 Funding: OPTIMIZE-HF and this study were supported by GlaxoSmithKline, Philadelphia, PA.

 Dr William S. Weintraub served as guest editor for this manuscript.

PII: S0002-8703(09)00205-1

doi: 10.1016/j.ahj.2009.03.011

American Heart Journal
Volume 157, Issue 6 , Pages 1018-1025 , June 2009

Article Tools

* Image Usage & Resolution